endralazine has been researched along with Heart Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braunwald, E; Colucci, WS | 1 |
| Evans, TR; Quyyumi, AA; Wagstaff, D | 2 |
| Hochrein, H; Lehmann, HU; Witt, E | 1 |
1 review(s) available for endralazine and Heart Failure
| Article | Year |
|---|---|
Vasodilator therapy of heart failure. Has the promissory note been paid?
Topics: Calcium Channel Blockers; Captopril; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Minoxidil; Pyridazines; Vasodilator Agents | 1984 |
3 other study(ies) available for endralazine and Heart Failure
| Article | Year |
|---|---|
Long-term beneficial effects of endralazine, a new arteriolar vasodilator at rest and during exercise capacity in chronic congestive heart failure.
Topics: Aged; Blood Pressure; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Pyridazines; Stroke Volume; Time Factors; Vasodilator Agents | 1984 |
Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Pyridazines; Stroke Volume; Vasodilator Agents | 1983 |
[Evaluation of a pyridopyridazine as a drug with marked antihypertensive properties (author's transl)].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Capillaries; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pulmonary Artery; Pyridazines; Vascular Resistance | 1977 |